Evaluation of Chest Pain: Acute Coronary Syndrome and Acute Aortic Syndrome

 

ESC/AHA/ACC/AATS classification

Class 1

Aortic dissection

Class 2

Intramural hematoma

Class 3

Discrete/Subtle dissection/Limited tear

Class 4

Penetrating atherosclerotic ulcer

Class 5

Iatrogenic and traumatic dissection


ESC, European Society of Cardiology; AHA, American Heart Association; ACC, American College of Cardiology; AATS, American Association for Thoracic Surgery


At our institution we use a conceptually different classification of acute aortic disorders that is based on the underlying pathology and allows for a broader spectrum of manifestations, particularly within the dissection category. We also consider symptomatic thoracic aortic aneurysms as an acute aortic syndrome, and treat IMH as a dissection variant or as an unspecific imaging finding rather than as a separate disease entity (Table 2).



Table 2.
Stanford conceptual classification of acute aortic syndromes

















1. Aortic dissection and dissection variants (diseased media)

1.a Classic aortic dissectiona

1.b Intramural hematoma variant

1.c Limited intimai tear (limited dissection)a

2. Penetrating atherosclerotic ulcer (diseased intima)a

3. Rupturing thoracic aortic aneurysma


a Classic aortic dissection, limited intimai tear, penetrating atherosclerotic ulcer and rupturing aneurysm are lesions that can occur with or without associated intramural hematoma.



ECG-Gated CT: Improved Chest Pain Triage in Patients with Acute Coronary and Acute Aortic Syndromes


Nowadays, fast scanner technology combined with heart-rate-reducing medication has made it possible to image the coronary arteries without motion artifacts in most patients. Indeed, state-of-the-art scanners acquire 64–320 cross-sections per rotation, depicting vascular details with a spatial resolution of <0.5 mm. ECG-synchronized, contrast-enhanced images of the heart and coronary arteries can be acquired in one to five heart cycles. The diagnostic performance of coronary CTA has been investigated extensively in patients with stable coronary artery disease (CAD). Using invasive angiography as a reference, coronary CTA is more sensitive (98–100%) than any other noninvasive technique [30]. Because of its high negative predictive value (99–100%), coronary CTA is recommended in patients with a low to intermediate probability of CAD and in patients with an inconclusive functional test [31]. A normal cardiac CT examination is associated with a low adverse cardiac event rate in the following years [32] The reported perpatient specificity (∼85%) is lower because stenosis severity is overestimated, often due to the presence of calcifications, but it is not inferior to that of other noninvasive techniques. In addition, radiation exposure has decreased dramatically over the past years, such that doses of <5 mSv are now common practice using state-of-the-art technology; moreover, very recent innovations permit doses under 1 mSv in selected patients [33]. Given the practical limitations of functional testing in the ED setting and the relatively low prevalence of CAD in patients visiting EDs, direct coronary visualization by CTA offers an attractive diagnostic alternative for the early triage of ACS patients.

CTA of the thorax and abdomen is a well-established imaging technique for many acute abnormalities of the aorta. Even without the use of ECG gating, CTA of the aorta has high sensitivity and specificity for the detection of acute thoracic aortic diseases and it has largely replaced conventional diagnostic angiography [34]. However, over the last decade it has become clear that the spectrum of acute aortic abnormalities also includes subtle yet important aortic lesions that evade nearly all cross-sectional imaging techniques, including non-gated CTA. Conversely, using ECG-gated CTA, the aortic root, coronary arteries, and valve apparatus can be accurately assessed preoperatively Finally, modern endovascular treatment options require much higher degrees of accuracy in the delineation of pathology and treatment planning: both the exact size and location of a primary intimai tear and the branching pattern of the aortic arch are affected by cardiac pulsation artifacts, and their suppression is highly desirable.


CT Protocols in Patients with Acute Chest Pain


The CT techniques used for the assessment of CAD are different from those used in patients with acute aortic diseases; thus, selection of the correct protocol is the first step in any CT imaging procedure and is based on clinical judgment by ED physicians.


Coronary CTA


The assessment of coronary stenosis requires coronary CTA of the highest quality. The scan range is restricted to the heart. Premedication of the patient with nitroglycerine and, above a prespecified heart rate (typically 65 bpm), with beta-blockers is necessary. The entire workflow needs to be well established, as the introduction of a coronary CTA program is not without substantial effort, even when all the technology is available. A guide on patient preparation, CT imaging protocols, CT imaging assessments, and reporting is provided below.


ECG-Gated CTA of the Aorta


In the evaluation of patients with acute aortic syndromes the goal in imaging is to eliminate or at least reduce pulsation artifacts. This can be achieved routinely even without beta-blockage. Nitroglycerine is also not required. The scan range always needs to include the entire aorta and iliofemoral access vessels as a road-map for endovascular treatment. Use of ECG-gating does not pose a major change of workflow for an established CT system operating around the clock. While routine use of ECG gating in the setting of acute aortic syndromes has several advantages, it may be an unnecessary effort outside of centers with large surgical and endovascular programs. If ECG gating is not routinely used for patients with acute aortic syndromes, a gated protocol should nevertheless be available to further evaluate indeterminate findings on a non-gated scan. Another benefit of routine ECG gating for thoracic aortic CTA is that it facilitates the implementation of ECG gating for acute coronary CTA programs.


Combined “Triple-Rule-Out” Protocol


While it is technically possible to build CT protocols that allow imaging and interpretation of the entire aorta, the coronary arteries, and the pulmonary vasculature, such studies are not performed at our institutions. A complete “triple-rule-out” protocol would require a longer injection of contrast agent (to opacify systemic and pulmonary arteries simultaneously), resulting in artifacts from the superior vena cava and the right heart. To perform a guideline-conforming work-up for aortic dissection, the scanning range would have to include not only the entire chest but also the entire abdominal aorta and iliofemoral access vessels, which implies greater radiation exposure. While it is possible to detect an aortic dissection using coronary CTA, and acute coronary abnormalities or abnormal myocardial enhancement can be identified on a gated CTA for evaluation of acute aortic syndrome, these situations tend to be rare. Some studies have suggested the limited efficacy of these protocols since they are likely to be ordered in patients with undifferentiated chest pain, who have a very low event rate for any of the syndromes [35]. Contrary to common belief, there is not a wide clinical overlap between ACS and acute aortic syndromes.


Challenges to the Implementation of a Coronary CT Program


While the potential diagnostic value of cardiac CT in the ED seems evident, there are practical obstacles that interfere with its widespread implementation. CT equipment with sufficient cardiac imaging capabilities (minimally a single-source 64-slice system), fully-trained technologists, and experienced cardiac CT readers are essential. Not all patients are eligible for cardiac CTA, including those with known CAD, cardiac arrhythmia, tachycardia, or severe obesity (typically BMI >40 kg/m2). CTA is associated with risks due to radiation exposure, although doses have decreased substantially over the past decade. The use of iodine-containing contrast media is contraindicated in patients with renal dysfunction or related allergies. The guidelines emphasize that the choice of test, whether CT or another modality, should be based on local expertise and the individual characteristics of the patient that affect eligibility [36]. More advanced CT technology, i.e., dual-source CT systems or wider detector arrays, can improve image quality in somewhat less suitable patients. Presently, few centers have a sufficient number of experienced personnel to offer cardiac CT around the clock. Current published guidelines on the practice of cardiac CT in the ED specify the requirements for and maintenance of certification for imaging centers, interpreting physicians, and medical staff [36].


Suggested Coronary CTA Approach


The following sections provide guidance based on professional society standards and encourage the use of the recommended practices [36]. Cardiac CT should be performed and interpreted in accordance with best practice standards as delineated in the imaging guidelines of the Society of Cardiovascular Computed Tomography (SCCT), using at least 64-slice technology and interpreted by physicians at least Core Cardiology Training Symposium (COCATS) level 2 or equivalent, SCCT level 2, or certified by the Certification Board of Computed Cardiovascular Tomography (CBCCT) [29]. Below is a summary of the standards that should be considered at every institution:


Patient Preparation



Contraindications




1.

Absolute: Iodinated contrast allergy not amenable to pre-treatment, pregnancy

 

2.

Relative: Renal insufficiency, multiple myeloma/ radioactive iodine therapy, untreated hyperthyroidism, inability to perform breath-hold for >15 s, cardiac rhythm (frequent ectopy/arrhythmia), unwillingness to abstain from metformin for 48 h after the CT examination.

 


Prior to Arrival




1.

Discontinue phosphodiesterase inhibitors for 48 h before the test.

 

2.

Consider abstaining from nonsteroidal anti-inflammatory agents.

 

3.

Consider 48-h abstention from metformin after the CT examination.

 

4.

Continue medications other than phosphodiesterase inhibitors/nonsteroidal anti-inflammatory drugs.

 

5.

No solids 4 h prior to the scan, but otherwise may continue usual intake of liquids and solid foods.

 


In the Scanner




1.

Patient positioning

a.

Heart centered within the gantry

 

b.

Appropriate placement of ECG leads

 

 

2.

Patient preparation

a.

A test breath-hold to monitor heart rate to decide on beta-blocker requirement and usage of prospective vs. retrospective gating

 

b.

Use of i.v. or oral beta blockers if heart rate is >60 bpm, e.g., 5–20 mg metoprolol i.v. or 50–100 mg atenolol 1 h before (exceptions can be made for CT scanners with high temporal resolution such as dual-source or flash)

 

c.

Use of nitroglycerin for coronary vasodilation, e.g., 400–800 µg sublingual nitroglycerin (one to two tabs).

 

 

Important: In patients abstaining from phosphodiesterase inhibitors 48 h before the test, no nitrates should be given during CT scan acquisition.


CT Imaging Protocol




1.

Iodinated contrast agent with at least 320 (or 300) mg iodine/mL.

a.

Injection rate of contrast agent: minimum of 5 ml/s and up to 8 mL/s in obese patients.

 

 

2.

Determination of optimal contrast timing using either a test bolus or a bolus trigger technique

 

3.

Amount of contrast: duration of scan but at least a 10-s injection.

 

4.

Minimizing the radiation exposure by choosing an appropriate field of view (at the level of the carina to the dome of the diaphragm).

 


Steps




1.

Scout: Topogram anteroposterior and/or lateral

 

2.

Coronary calcium assessment

a.

Prospective ECG-gated/triggered, low-dose non-contrast CT scan to determine coronary artery calcification

 

b.

An Agatston score of >800

 

c.

No contrast-enhanced CTA

 

 

3.

Assessment of coronary atherosclerotic plaque and stenosis: Prospective ECG-triggered or retrospective ECG-gated CT imaging using tube modulation technique

a.

Maximal temporal and spatial resolution of the equipment

 

b.

Candidates for prospective triggering: regular heart rate <62 bpm during breath-hold after beta-blockade, no cardiac arrhythmias or premature beats prior to or during test breath-hold and <400 AS

 

 

4.

Adjusting kvp to BMI:

a.

100 kvp if BMI <30 kg/m2 AND body weight <220 pounds

 

b.

120 kvp if BMI >30 kg/m2

 

c.

For retrospective gating: use radiation safety options according to the manufacturer’s guidelines (i.e., tube current modulation, width of the full tube current according to heart rate, hybrid techniques such as padding)

 

 

5.

Image reconstruction

a.

ECG editing in patients with premature beats

 

b.

Reconstruction with approximately 50% overlap (e.g., 0.75-mm slice thickness with 0.4-mm increment or 0.6 mm slice thickness with 0.3-mm overlap)

 

c.

Reconstruction of the number of series necessary to eliminate motion artifacts, typically two data sets, but more if required (i.e., for the right coronary artery) in mid-diastole (65–80%) and end systole (35–45%) if retrospective technique was used.

 

 


Left Ventricular Function




1.

For either prospective (extending the gate) and retrospective ECG gating, data on global and regional left ventricular function should be collected and assessed.

 

2.

Typically 1.5- to 2-mm-thick axial images are reconstructed at 10% increments (10 phases) for singlesource CT scanners or 5% increments (20 phases) for dual-source CT scanners throughout the cardiac cycle with a reduced pixel matrix of 256×256.

 


Full Field of View




1.

If incidental findings are assessed: reconstruction of a data set of 3-mm-thick axial images, covering the portions of the thorax acquired during the cardiac CT scan

 

2.

Reconstruction of a field of view optimized for coverage of the heart.

 


Documentation of Radiation Exposure


Radiation exposure should be reported as the CT dose index per volume (CTDIvol), expressed in mGy, for a given anatomic coverage (e.g., the heart) with or without the corresponding dose-length product (in mGy per cm) for each diagnostic acquisition (e.g., for the calcium score and the CT angiographic acquisition), together with a total dose length product (DLP).


CT Parameters To Be Reported


A diagnostic testing report should contain information on beta-blocker and nitrate administration, imaging sequences performed overall contrast administration, including the contrast agent used, and the overall radiation dose.


Report on the Coronary Arteries




1.

Arterial distribution (right or left dominant, co-dominant)

a.

Rate overall image quality as interpretable/uninterpretable; specify non-evaluable segments/arteries and reason

 

 

2.

Presence and extent of coronary atherosclerotic plaque (none, calcified, non-calcified, both) according to American Heart Association (AHA) classification per vessel and optionally per 17 coronary segments, including presence and severity of a significant coronary stenosis (>70% luminal narrowing) per vessel and optionally per 17 coronary segments.

a.

Degree of luminal narrowing should be as follows: normal: 0%, non-significant/minor disease: 1–49%, moderate disease: 50–69% (except left main, where >50% is considered significant), significant disease: 70–99%, occluded: 100%.

 

 


Evaluation of the Left Ventricle




1.

Regional left ventricular (LV) dysfunction including wall motion and wall thickening of the myocardium assessed qualitatively based on the American Heart Association, American College of Cardiology, American Society of Echocardiography (AHA/ACC/ASE) 17-segment model.

 

2.

Whether the location of regional dysfunction matches the stenosis location.

 

3.

Regional LV dysfunction has to be present in at least two contiguous myocardial segments or in one segment visualized in two different views to be considered a true-positive finding.

 

4.

Each LV segment is graded as normal, hypokinetic (impaired contraction), akinetic (absent contraction), dyskinetic (paradoxical outward wall motion during systole without aneurysm formation in diastole) or aneurysmal.

 

5.

Global LV function as normal, mildly, moderately or severely impaired.

 

6.

Non-cardiac finding assessment should include aortic dissection, pulmonary embolism, pulmonary nodules, pneumonia, pneumothorax, pericardial effusion, hiatal hernia, rib fractures.

 


Coronary CTA in Patients with Suspected ACS


The absence of plaque on CTA excludes ACS (sensitivity 100%), while obstructive CAD (>50% stenosis) does not (sensitivity 77%); only half of the patients with obstructive CAD on CTA have acute coronary disease. Several randomized controlled trials have investigated the safety and economic performance of cardiac CT in acute chest pain (Table 3) [3739]. Taken together, the three trials comprised more than 3000 patients. Follow-up analysis demonstrated that, based on the CTA results, not a single patient was discharged with a missed diagnosis of ACS. These trials demonstrated the efficiency of CTA compared to the standard of care (SOC) as evidenced by a reduction in length of stay, hospital admissions, and ED cost, while overall hospital costs remained similar to those of the SOC, driven by a higher rate of invasive angiography and revascularizations. Across the trials, patients randomized to CTA more often underwent cardiac catheterization (8.4% vs. 6.3%) and percutaneous coronary intervention (4.6% vs. 2.6%). Unfortunately, the trials were not powered to prove that higher sensitivity for the detection of obstructive CAD by CTA, with subsequently increased revascularization rates, also results in a better clinical outcome. Additionally, radiation exposure will be higher for CTA when the SOC consists of exercise tests and stress echocardiography. In summary, these trials have established cardiac CT as a viable alternative to functional testing in the triage of low-risk patients with acute chest pain. Several studies demonstrated that CTA findings of plaque, stenosis, and ventricular function accurately predict adverse cardiac events over the next 6 months to 2 years. While patients without CAD remain virtually event-free, those with non-obstructive CAD have a slightly increased risk, and those with obstructive CAD are at the highest risk [32].

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Nov 21, 2016 | Posted by in CARDIOLOGY | Comments Off on Evaluation of Chest Pain: Acute Coronary Syndrome and Acute Aortic Syndrome

Full access? Get Clinical Tree

Get Clinical Tree app for offline access